CD38 as a PET Imaging Target in Lung Cancer

Daratumumab (Darzalex, Janssen Biotech) is a clinically approved antibody targeting CD38 for the treatment of multiple myeloma. However, CD38 is also expressed by other cancer cell types, including lung cancer, where its expression or absence may offer prognostic value. We therefore developed a PET...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Mol Pharm
Asıl Yazarlar: Ehlerding, Emily B., England, Christopher G., Jiang, Dawei, Graves, Stephen A., Kang, Lei, Lacognata, Saige, Barnhart, Todd E., Cai, Weibo
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2017
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5552967/
https://ncbi.nlm.nih.gov/pubmed/28573863
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acs.molpharmaceut.7b00298
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller